The Philippines is recognized as Southeast Asia’s pioneer in agricultural biotechnology. It was the first in the region to establish a regulatory framework for genetically modified (GM) crops. It ...
Researchers unveil a groundbreaking chemical reaction for efficient drug development and protein science by manipulating ...
BARC JRF 2026 recruitment: The Bhabha Atomic Research Centre has opened online applications for 105 Junior Research Fellowships under the JRF-2026 programme. Eligible candidates with degrees in ...
Overview of BARC JRF Recruitment 2026 BARC JRF Recruitment 2026: The Bhabha Atomic Research Centre (BARC) has announced the opening of applications for the Junior Research Fellowship (JRF) for the ...
In this GEN Learning Lab, our expert panelists Linda Orzolek, MS, MB, Xuhuai Ji, MD, PhD, and Christina Chang, PhD, will discuss the current landscape of imaging- and next-generation sequencing-based ...
Celcuity develops targeted cancer therapies and diagnostics, leveraging proprietary technology to advance precision oncology solutions.
Deramiocel has the potential to become the first therapy to address both skeletal and cardiac manifestations of Duchenne ...
The West Bengal JEE board has issued the official notification. The notification outlines the full schedule, including the ...
Newspoint on MSN
NIB: Recruitment for several posts at the National Institute of Biological Sciences; 12th pass candidates can also apply; know the conditions
NIB Vacancy 2025: The National Institute of Biologicals (NIB) has released an official notification for recruitment to various positions for the year 2026. Under this recruitment drive, eligible ...
The European Medicines Agency (EMA) has officially qualified PolTREG to submit an application for marketing authorization in the European Union for the PolTREG-T1D cell preparation. GDANSK, Poland ...
Partnership supported by funding from Google Cloud will increase Decoy's computational peptide design bandwidth by 25-100x CAMBRIDGE, Mass. and HOUSTON, March 11, ...
Eupraxia Pharmaceuticals Inc. ('Eupraxia” or the 'Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results